Literature DB >> 9132335

Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

D G Ebo1, P G Bracke, L S De Clerck, L M Francx, W J Stevens.   

Abstract

This case report describes a patient with Behçet's syndrome with sustained anticardiolipin antibodies presenting a vena cava inferior thrombosis in a period of anabolic steroid use. The vascular manifestations and occurrence of antiphospholipid antibodies in Behçet's syndrome are reviewed. The possible thrombogenicity of anabolic steroids is reemphasized.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9132335     DOI： 10.1007/bf02238771

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Absence of lupus anticoagulants in Behçet's disease.

Authors:  D Bang; H G Ji; Y S Choi; S Lee
Journal:  Yonsei Med J       Date:  1991-12       Impact factor: 2.759

3.  [Anticardiolipin antibodies in Behçet's disease].

Authors:  M Hamza; O Meyer
Journal:  Presse Med       Date:  1986 Jul 5-12       Impact factor: 1.228

4.  Absence of antiphospholipid antibodies in Behçet's disease.

Authors:  M Karmochkine; M C Boffa; B Wechsler; J C Piette; P Godeau
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

5.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data.

Authors:  S Lakhanpal; K Tani; J T Lie; K Katoh; Y Ishigatsubo; T Ohokubo
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

7.  [Behçet's disease. 316 cases].

Authors:  S Benamour; B Zeroual; R Bennis; A Amraoui; S Bettal
Journal:  Presse Med       Date:  1990-10-06       Impact factor: 1.228

8.  Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Behçets disease.

Authors:  A N al-Dalaan; S R al-Ballaa; M A al-Janadi; S Bohlega; S Bahabri
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

9.  Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease.

Authors:  R M Pereira; C R Gonçalves; C Bueno; E de S Meirelles; W Cossermelli; R M de Oliveira
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

10.  [Deep venous thrombosis in Behçet's disease. 106 localizations in a series of 177 patients].

Authors:  B Wechsler; J C Piette; J Conard; L T Huong Du; O Blétry; P Godeau
Journal:  Presse Med       Date:  1987-04-18       Impact factor: 1.228
View more
  1 in total

Review 1.  Thrombosis in Behcet's disease: report of a case followed by a systematic review using the methodology of evidence-based medicine.

Authors:  P W Radke; E R Schwarz; H Groesdonk; J Graf; U Janssens
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.